Menu UF Health Home Menu

Brusko Lab Defines Distinct Treg Subsets

TIGIT and CD226 provide important phenotypic markers for assessing the role of Tregs in health and disease


UFDI Clinical Trial Shows Promising Results

Immune therapy for treating type 1 diabetes challenges existing paradigms

Helmsley Press Release

Helmsley Grant to UFDI

During a live webinar, physicians and medical researchers from around the globe learned that a $3.3MM grant has been awarded to nPOD collaborators at UM and UF.

Focused on diabetes

Our Research Focus

Our laboratory aims to harness the power regulatory T-cells to control unwanted immune responses to deliver a cure for type 1 diabetes.

20150423 Gennie 3

Our Staff

From undergraduate students to post-doctoral fellows – every set of hands is important.


Our Publications

View how Dr. Brusko’s research has progressed and see where our research currently stands.

Prev Next

Contact Us

I am among those who think that science has great beauty. A scientist in his laboratory is not only a technician: he is also a child placed before natural phenomena which impress him like a fairy tale.

-Marie Curie